(Q38344088)

2 September 2017

1 reference

title

Paths to Alzheimer's disease prevention: from modifiable risk factors to biomarker enrichment strategies (English)

1 reference

2 September 2017

0 references

0 references

1 reference

2

B Dubois

0 references

author name string

S Lista

series ordinal

1

1 reference

2 September 2017

H Hampel

series ordinal

3

1 reference

2 September 2017

language of work or name

1 reference

1 February 2015

1 reference

The Journal of Nutrition, Health and Aging

2 September 2017

1 reference

2 September 2017

19

1 reference

2 September 2017

154-163

1 reference

2 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s12603-014-0515-3

2 September 2017

0 references

cites work

The global prevalence of dementia: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Global prevalence of dementia: a Delphi consensus study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Future directions in Alzheimer's disease from risk factors to prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Alzheimer's disease: clinical trials and drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Amyloid precursor protein processing and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer's disease and the tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Linking lipids to Alzheimer's disease: cholesterol and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Alterations in metabolic pathways and networks in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Alzheimer disease: from biomarkers to diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Development of biomarkers to chart all Alzheimer's disease stages: the royal road to cutting the therapeutic Gordian Knot

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

The role of genetics for biomarker development in neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Biological markers of amyloid beta-related mechanisms in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Total and phosphorylated tau protein as biological markers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

The future of blood-based biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Blood and plasma-based proteomic biomarker research in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Clinical and research diagnostic criteria for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

CSF biomarker variability in the Alzheimer's Association quality control program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Multiplex biomarkers in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Clinical and biomarker changes in dominantly inherited Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Neurodegenerative disease biomarkers: guideposts for disease prevention through early diagnosis and intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Worldwide Alzheimer's disease neuroimaging initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Dementia prevention: current epidemiological evidence and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Advances in the prevention of Alzheimer's disease and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Development of vascular risk factors over 15 years in relation to cognition: the Hoorn Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Type 2 diabetes as a risk factor for Alzheimer's disease: the confounders, interactions, and neuropathology associated with this relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Mediterranean diet in predementia and dementia syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Diet and Alzheimer’s disease risk factors or prevention: the current evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Adherence to a Mediterranean diet, cognitive decline, and risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Alcohol consumption in mild cognitive impairment and dementia: harmful or neuroprotective?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Alcohol drinking and cognitive functions: findings from the Cardiovascular Risk Factors Aging and Dementia (CAIDE) Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

The impact of alcohol on Alzheimer's disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer's disease: a population-based cardiovascular risk factors, aging and dementia study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

The effect of midlife physical activity on cognitive function among older adults: AGES--Reykjavik Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Physical activity, diet, and risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Physical activity and Alzheimer disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Imaging and cognitive reserve studies predict dementia in presymptomatic Alzheimer's disease subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Education increases reserve against Alzheimer's disease--evidence from structural MRI analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Long-term observation of a multicomponent cognitive intervention in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Depression as a risk factor for Alzheimer disease: the MIRAGE Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): study design and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Prevention of dementia by intensive vascular care (PreDIVA): a cluster-randomized trial in progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Addressing population aging and Alzheimer's disease through the Australian imaging biomarkers and lifestyle study: collaboration with the Alzheimer's Disease Neuroimaging Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Evidence for ordering of Alzheimer disease biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Testing the right target and right drug at the right stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Prevent Alzheimer's disease by 2020: a national strategic goal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Midlife cardiovascular risk factors and late cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12603-014-0515-3

Effects of a newly developed cognitive intervention in amnestic mild cognitive impairment and mild Alzheimer's disease: a pilot study

21 January 2018

1 reference

12 December 2020

Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments

1 reference

12 December 2020

Perspectives for multimodal neurochemical and imaging biomarkers in Alzheimer's disease

1 reference

12 December 2020

Association of mediterranean diet with mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis

1 reference

12 December 2020

Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?

1 reference

12 December 2020

Novel lipid signaling pathways in Alzheimer's disease pathogenesis

1 reference

12 December 2020

Cognitive intervention in Alzheimer disease.

1 reference

12 December 2020

Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative

1 reference

12 December 2020

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

1 reference

12 December 2020

Biomarkers in clinical trials for neurodegenerative diseases: Regulatory perspectives and requirements

1 reference

12 December 2020

Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.

1 reference

12 December 2020

The genetics of Alzheimer's disease

1 reference

12 December 2020

The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited

1 reference

12 December 2020

The interplay of neurotransmitters in Alzheimer's disease.

1 reference

12 December 2020

10.1007/S12603-014-0515-3

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference